Magnusdottir, R.
Gohin, S.
ter Heegde, F.
Hopkinson, M.
McNally, I.F.
Fisher, A.
Upton, N.
Billinton, A.
Chenu, C. http://orcid.org/0000-0002-5727-6070
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (642720)
Article History
Received: 8 January 2021
Accepted: 3 May 2021
First Online: 2 June 2021
Declarations
:
: All animal procedures were performed by trained investigators under PPL 70/8782 in accordance with the Animal (Scientific Procedures) Act, 1986 and the Royal Veterinary Colleges’ Animal Welfare and Ethical Review Body. ARRIVE guidelines were followed for experimental mice and procedures.
: Ran Magnusdottir, Freija Ter Heegde, Stephanie Gohin, Mark Hopkinson, Isabella Faye McNally, Amy Fisher, Neil Upton and Chantal Chenu declare that they have no conflict of interest. Andy Billinton is a shareholder of AZ and GSK, and currently an employee of NodThera Ltd.